-- CORRECTED: Genentech's profit up on Avastin
-- 
-- Wed Jul 11, 2007 4:33pm EDT
-- http://www.reuters.com/article/2007/07/11/us-genentech-earns-idUSWEN927920070711

 

 (Corrects to show that cost-cutting not contributing to profits)    

 LOS ANGELES  (Reuters) - Genentech Inc. DNA.N said second-quarter profit on Wednesday rose 41 percent, fueled by growth from its cancer drug Avastin. The world's second-largest biotechnology company had net income of $747 million, or 70 cents per share, compared with year-earlier net income of $531 million, or 49 cents per share.